Maurizio Martelli

Pubblicazioni

Titolo Pubblicato in Anno
Neutrophil to lymphocyte ratio in myelofibrosis patients treated with ruxolitinib may predict prognosis and rate of discontinuation EUROPEAN JOURNAL OF HAEMATOLOGY 2024
Ropeginterferon alfa-2b treatment in a young patient with multi-refractory polycythemia vera and double JAK2 gene mutation: a case report FRONTIERS IN ONCOLOGY 2024
Safety and Efficacy of TKIs in very Elderly Patients (≥75 Years) with Chronic Myeloid Leukemia JOURNAL OF CLINICAL MEDICINE 2024
Effect of daratumumab on stem cell yields in patients with newly diagnosed multiple myeloma: a report from the Multiple Myeloma Group BONE MARROW TRANSPLANTATION 2024
Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study LEUKEMIA 2024
Impact of Daratumumab on Stem Cell Mobilization and Transplant in Patient with Newly Diagnosed Multiple Myeloma: A Real Word Single-Centre Study MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES 2024
Leucocytosis during induction therapy with all-trans-retinoic acid and arsenic trioxide in acute promyelocytic leukaemia predicts differentiation syndrome and treatment-related complications BRITISH JOURNAL OF HAEMATOLOGY 2024
Real-Life Management of FLT3-Mutated AML: Single-Centre Experience over 24 Years CANCERS 2024
Treatment free remission (TFR) after second-generation tyrosine kinase inhibitors (2G-TKIs) treatment in chronic myeloid leukemia (CML): from feasibility to safety EXPERT OPINION ON DRUG SAFETY 2024
Pharmacotherapeutic advances for chronic myelogenous leukemia: beyond tyrosine kinase inhibitors EXPERT OPINION ON PHARMACOTHERAPY 2024
Response Rates and Transplantation Impact in Patients with Relapsed Acute Promyelocytic Leukemia CANCERS 2024
LEUKOCYTOSIS IN LOW-INTERMEDIATE RISK ACUTE PROMYELOCYTIC LEUKEMIA DURING ATRA-ATO INDUCTION THERAPY: A REAL-LIFE STUDY HEMASPHERE 2024
Benefits and Safety of Empiric Antibiotic Treatment Active Against KPC-K. pneumoniae in Febrile Neutropenic Patients with Acute Leukemia Who are Colonized with KPC-K. pneumoniae. A 7-Years Retrospective Observational Cohort Study INFECTION AND DRUG RESISTANCE 2023
Late appearance of JAK2 mutated polycythaemia vera in a patient with typical chronic myeloid leukaemia on imatinib: Speculations about role of therapeutic pressure and of secondary genetic events LEUKEMIA RESEARCH 2023
Whole body MRI with Difusion Weighted Imaging versus 18F‑fuorodeoxyglucose‑PET/CT in the staging of lymphomas LA RADIOLOGIA MEDICA 2023
Long-Term Host Immune Modulation Following Tisagenlecleucel Administration in Patients with Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemia CANCERS 2023
Whole body MRI with Diffusion Weighted Imaging versus 18F-fluorodeoxyglucose-PET/CT in the staging of lymphomas LA RADIOLOGIA MEDICA 2023
Efficacy of Residual Site Radiation Therapy (ISRT) in Patients with Primary Mediastinal Lymphoma with Deauville Score 4 Following R-CHT: Results of a Retrospective Mono Institutional Study JOURNAL OF CLINICAL MEDICINE 2023
Case Report: Infectious prophylaxis in hematological malignancies FRONTIERS IN ONCOLOGY 2023
Achieving the Cure of Follicular Lymphoma: is it Time to Finalize Treatment Strategies to Reach This Goal in a Subset of Patients? MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES 2023

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma